USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ASKLEPIOS BIOPHARMACEUTICAL, INC.
City: CHAPEL HILL
State: NC
Zip+4: 27517
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $3,133,300.00 3

Award List:

rAAV Revitalized Structural Allografts

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Richard J. Samulski
Award Amount: $157,070.00
Abstract:
DESCRIPTION (provided by applicant): Repair of large structural bone defects remains a major problem in orthopaedic reconstruction surgery due to the limited supply of cortical bone autograft and the poor long-term outcomes obtained with structural allografts. While there is no substitute for… More

Preclinical Development of AAV-Galanin for Epilepsy

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $282,210.00
Abstract:
DESCRIPTION (provided by applicant): This proposal seeks to leverage proprietary technical advances in Adeno-Associated Virus (AAV) vector mediated gene therapy to develop an AAV based Galanin gene delivery for the treatment of epilepsy. Asklepios Biopharm aceutical, Inc. (Askbio) has obtained… More

Preclinical Studies Supporting Phase Ib Study of Minidystrophin Gene in AAV Vecto

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $2,694,020.00
Abstract:
DESCRIPTION (provided by applicant): This proposal intends to advance the regional delivery of a chimeric adeno-associated virus (rAAV)-based, highly-truncated dystrophin (minidystrophin) gene therapy for the treatment of Duchenes Muscular Dystrophy (DMD). Experiments focus on completing… More